Technology
Health
Biotechnology

Alpine Immune Sciences

$4.05
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.20 (-4.71%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell ALPN and other stocks, options, ETFs, and crypto commission-free!

About ALPN

Alpine Immune Sciences, Inc. Common Stock, also called Alpine Immune Sciences, is a development-stage pharmaceutical company, which engages in the discovering of protein-based immunotherapies therapies targeting the immune synapse to treat cancer, autoimmune, and inflammatory disorders. Read More It offers Immunotherapy, Immune Synapse, vIgD Platform Technology, and TIP Program. The company was founded in 2015 and is headquartered in Seattle, WA.

Employees
48
Headquarters
Seattle, Washington
Founded
2015
Market Cap
76.10M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
14.98K
High Today
$4.24
Low Today
$4.15
Open Price
$4.15
Volume
2.12K
52 Week High
$8.59
52 Week Low
$3.66

Collections

Technology
Health
Biotechnology
Pharmaceutical
Cancer Prevention
2015 IPO
US
North America

ALPN Earnings

-$0.88
-$0.71
-$0.54
-$0.37
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 8, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.